These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9380234)

  • 1. The impact of residual renal function on the adequacy of peritoneal dialysis.
    Lameire NH
    Nephron; 1997; 77(1):13-28. PubMed ID: 9380234
    [No Abstract]   [Full Text] [Related]  

  • 2. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of residual renal function on the adequacy of peritoneal dialysis.
    Lameire N; Van Biesen W
    Perit Dial Int; 1997; 17 Suppl 2():S102-10. PubMed ID: 9163808
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Automated peritoneal dialysis: impact on residual kidney function and peritoneal membrane permeability].
    Gallar P; Ortega O; Gutiérrez M; Carreño A; Domínguez-Gil B; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2001; 21(2):200-3. PubMed ID: 11464654
    [No Abstract]   [Full Text] [Related]  

  • 6. Designing dialysis prescriptions.
    Manuel A; Gray B; Coulis N; Brunier G; Desson F; Paton MA; Tobe S
    Adv Perit Dial; 1996; 12():136-42. PubMed ID: 8865888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarifying K/DOQI's guideline targets for peritoneal dialysis adequacy.
    Prowant BF
    Nephrol Nurs J; 2001 Aug; 28(4):445-6, 450. PubMed ID: 12143468
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship among asymmetric dimethylarginine (ADMA) levels, residual renal function, and left ventricular hypertrophy in continuous ambulatory peritoneal dialysis patients.
    Ebinç FA; Erten Y; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Mutluay R; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(4):401-6. PubMed ID: 18569913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of nutritional status, dialysis adequacy, and residual renal function on the response to hepatitis B vaccination in peritoneal dialysis patients.
    Dacko C; Holley JL
    Adv Perit Dial; 1996; 12():315-7. PubMed ID: 8865927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal dialysis adequacy and risk of death.
    Rocco M; Soucie JM; Pastan S; McClellan WM
    Kidney Int; 2000 Jul; 58(1):446-57. PubMed ID: 10886593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with chronic peritoneal dialysis in infants.
    Qamar IU; Balfe JW
    Child Nephrol Urol; 1991; 11(3):159-64. PubMed ID: 1723351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intermittent peritoneal dialysis and continuous ambulatory peritoneal dialysis].
    Radovanović Lj; Popović J; Radlović O
    Srp Arh Celok Lek; 1988; 116(11-12):967-76. PubMed ID: 3247614
    [No Abstract]   [Full Text] [Related]  

  • 13. Peritoneal dialysis.
    Nolph KD; Twardowski ZJ; Khanna R
    ASAIO Trans; 1986; 32(1):11-6. PubMed ID: 3778693
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous ambulatory peritoneal dialysis and pulmonary function.
    Smith WG; Patel KR; Briggs JD; Junor BJ
    Scott Med J; 1983 Oct; 28(4):355-6. PubMed ID: 6648501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clearance of urea, creatinine, beta 2 microglobulin and the loss of proteins in treatment with continuous ambulatory peritoneal dialysis].
    Kozjak D; Prejac M; Jeren-Struić B; Gudelj J; Kovarbasić B
    Lijec Vjesn; 1982; 104(11-12):532-5. PubMed ID: 6764943
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Taniguchi M; Yoshida H; Tokumoto M; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Kitazono T
    Ther Apher Dial; 2014 Oct; 18(5):383-90. PubMed ID: 24674095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The optimization of continuous ambulatory peritoneal dialysis.
    Oreopoulos DG
    Kidney Int; 1999 Mar; 55(3):1131-49. PubMed ID: 10027956
    [No Abstract]   [Full Text] [Related]  

  • 18. Can peritoneal dialysis be maintained in patients without residual renal function?
    Lye WC
    Perit Dial Int; 1999; 19 Suppl 2():S329-31. PubMed ID: 10406541
    [No Abstract]   [Full Text] [Related]  

  • 19. Targets in CAPD and APD prescription.
    Blake PG
    Perit Dial Int; 1996; 16 Suppl 1():S143-6. PubMed ID: 8728181
    [No Abstract]   [Full Text] [Related]  

  • 20. [Factors related to residual renal function loss in patients in peritoneal dialysis].
    Munguía-Miranda C; Ventura-García Mde J; Ávila-Díaz M; Orihuela-Rodríguez O; Paniagua-Sierra JR
    Rev Med Inst Mex Seguro Soc; 2015; 53(5):578-83. PubMed ID: 26383807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.